---
figid: PMC4541356__eye201582f6
figlink: /pmc/articles/PMC4541356/figure/fig6/
number: Figure 6
caption: The RAS/RAF/MEK/ERK signal transduction pathway. Extracellular signaling
  ligands bind to receptor tyrosine kinases in the cell membrane. This results in
  activation of RAS, which in turn activates RAF. RAF phosphorylates and activates
  MEK. MEK phosphorylates and activates ERK. Once activated, ERK translocates to the
  nucleus where it binds to transcription factors to stimulate cell growth and proliferation.
  Mutations resulting in abnormal activation of this pathway may contribute to many
  human cancers.
pmcid: PMC4541356
papertitle: 'MEK inhibitors: a new class of chemotherapeutic agents with ocular toxicity.'
reftext: K E Duncan, et al. Eye (Lond). 2015 Aug;29(8):1003-1012.
pmc_ranked_result_index: '85193'
pathway_score: 0.9057941
filename: eye201582f6.jpg
figtitle: RAS/RAF/MEK/ERK signal transduction pathway
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4541356__eye201582f6.html
  '@type': Dataset
  description: The RAS/RAF/MEK/ERK signal transduction pathway. Extracellular signaling
    ligands bind to receptor tyrosine kinases in the cell membrane. This results in
    activation of RAS, which in turn activates RAF. RAF phosphorylates and activates
    MEK. MEK phosphorylates and activates ERK. Once activated, ERK translocates to
    the nucleus where it binds to transcription factors to stimulate cell growth and
    proliferation. Mutations resulting in abnormal activation of this pathway may
    contribute to many human cancers.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K1
  - MAP2K2
  - BRAF
  - MAPK1
  - ARAF
  - TXN
  - NRAS
  - KRAS
  - RAF1
  - MAPK3
  - HRAS
  - PD-098059
  - PD-0325901
  - AZD6244
  - Trametinib
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Txn
  symbol: TXN
  source: hgnc_symbol
  hgnc_symbol: TXN
  entrez: '7295'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
chemicals:
- word: PD-098059
  source: MESH
  identifier: C093973
- word: PD-0325901
  source: MESH
  identifier: C506614
- word: AZD6244
  source: MESH
  identifier: C517975
- word: Trametinib
  source: MESH
  identifier: C560077
diseases: []
---
